HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?

por Simões-Pires, Claudia, Zwick, Vincent, Nurisso, Alessandra, Schenker, Esther, Carrupt, Pierre-Alain, Cuendet, Muriel
Publicado 2013

Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6

por Traoré, Mohamed D. M., Zwick, Vincent, Simões-Pires, Claudia A., Nurisso, Alessandra, Issa, Mark, Cuendet, Muriel, Maynadier, Marjorie, Wein, Sharon, Vial, Henri, Jamet, Helene, Wong, Yung-Sing
Publicado 2017